We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
Supernus Pharmaceuticals
SUPN
$2.44B
| $4.13M | ﹤0.01% |
88,756
-9,501
| -10% | -$456K |
2022 Q2
16 quarters
|
|
2127
Alumis Inc
ALMS
$871M
| $4.12M | ﹤0.01% |
146,437
-245
| -0.2% | -$5.7K |
2025 Q2
4 quarters
|
|
2128
AerSale
ASLE
$231M
| $4.12M | ﹤0.01% |
651,918
+125,956
| +24% | +$823K |
2024 Q1
9 quarters
|
|
2129
Entegris
ENTG
$23.6B
| $4.12M | ﹤0.01% |
23,531
+1,440
| +7% | +$208K |
2023 Q4
10 quarters
|
|
2130
AMC Entertainment Holdings
AMC
$2.73B
| $4.12M | ﹤0.01% |
2,166,091
+1,528,917
| +240% | +$2.63M |
2025 Q3
3 quarters
|
|
2131
Mineralys Therapeutics
MLYS
$1.61B
| $4.11M | ﹤0.01% |
152,504
+3,418
| +2% | +$93.8K |
2025 Q1
5 quarters
|
|
2132
ARKO Corp
ARKO
$425M
| $4.11M | ﹤0.01% |
511,505
+214,067
| +72% | +$1.5M |
2022 Q4
14 quarters
|
|
2133
Embraer S.A. ADS
EMBJ
$13.1B
| $4.1M | ﹤0.01% |
65,181
-32,676
| -33% | -$2.01M |
2024 Q2
8 quarters
|
|
2134
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.84B
| $4.09M | ﹤0.01% |
37,501
-521
| -1% | -$53.7K |
2025 Q1
5 quarters
|
|
2135
Parke Bancorp
PKBK
$383M
| $4.06M | ﹤0.01% |
122,410
+73,201
| +149% | +$2.25M |
2025 Q2
4 quarters
|
|
2136
iShares Global Tech ETF
IXN
$8.89B
| $4.05M | ﹤0.01% |
28,049
+17,636
| +169% | +$2.27M |
2025 Q3
3 quarters
|
|
2137
Biglari Holdings Class B
BH
$1.25B
| $4.04M | ﹤0.01% |
9,490
+3,556
| +60% | +$1.11M |
2025 Q2
4 quarters
|
|
2138
Schwab US TIPS ETF
SCHP
$16.5B
| $4.04M | ﹤0.01% |
152,530
-10,405
| -6% | -$278K |
2024 Q4
6 quarters
|
|
2139
Fulcrum Therapeutics
FULC
$283M
| $4.04M | ﹤0.01% |
1,103,261
+560,096
| +103% | +$3.41M |
2025 Q4
2 quarters
|
|
2140
iShares US Consumer Discretionary ETF
IYC
$1.22B
| $4.04M | ﹤0.01% |
39,932
+5,807
| +17% | +$588K |
2025 Q2
4 quarters
|
|
2141
Tempus AI
TEM
$13.2B
| $4.03M | ﹤0.01% |
+69,744
| New | +$3.5M |
2026 Q2
0 quarters
|
|
2142
iShares US Aerospace & Defense ETF
ITA
$12.2B
| $4.03M | ﹤0.01% |
16,604
+12,371
| +292% | +$2.82M |
2025 Q4
2 quarters
|
|
2143
Nu Skin
NUS
$226M
| $4.02M | ﹤0.01% |
789,131
-447,207
| -36% | -$2.86M |
2013 Q2
52 quarters
|
|
2144
Pacira BioSciences
PCRX
$1.45B
| $4.02M | ﹤0.01% |
158,511
+4,213
| +3% | +$100K |
2023 Q1
13 quarters
|
|
2145
BJ's Restaurants
BJRI
$1.33B
| $4.01M | ﹤0.01% |
65,957
+12,291
| +23% | +$538K |
2022 Q3
15 quarters
|
|
2146
Ryman Hospitality Properties
RHP
$9.19B
| $4M | ﹤0.01% |
31,122
+974
| +3% | +$108K |
2013 Q4
50 quarters
|
|
2147
Vanguard Financials ETF
VFH
$13.4B
| $3.99M | ﹤0.01% |
30,330
-648
| -2% | -$82.7K |
2024 Q4
6 quarters
|
|
2148
Woodside Energy
WDS
$44.8B
| $3.98M | ﹤0.01% |
205,879
+99,822
| +94% | +$2.22M |
2025 Q1
5 quarters
|
|
2149
Orange County Bancorp
OBT
$519M
| $3.97M | ﹤0.01% |
108,045
+78,851
| +270% | +$2.74M |
2025 Q3
3 quarters
|
|
2150
Castle Biosciences
CSTL
$1.14B
| $3.97M | ﹤0.01% |
166,567
+101,687
| +157% | +$2.26M |
2024 Q4
6 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.